December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Retinal Changes After Transpupillary Thermotherapy For Choroidal Neovascularization
Author Affiliations & Notes
  • H Yamaji
    Dept Ophthalmology Okayama Univ Medical School Okayama Japan
  • F Shiraga
    Okayama University Medical School Dept of Opthalmolology Okayama Japan
  • J Endo
    Okayama University Medical School Dept of Ophthalmology Okayama Japan
  • M Kato
    Okayama University Medical School Dept of Ophthalmology Okayama Japan
  • H Nomoto
    Okayama University Medical School Dept of Ophthalmology Okayama Japan
  • H Ohtsuki
    Okayama University Medical School Dept of Ophthalmology Okayama Japan
  • Footnotes
    Commercial Relationships   H. Yamaji, None; F. Shiraga, None; J. Endo, None; M. Kato, None; H. Nomoto, None; H. Ohtsuki, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4414. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H Yamaji, F Shiraga, J Endo, M Kato, H Nomoto, H Ohtsuki; Retinal Changes After Transpupillary Thermotherapy For Choroidal Neovascularization . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4414.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate retinal damages shortly after transpupillary thermotherapy (TTT) for age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV). Methods: Fourteen consecutive eyes of 14 patients with occult or classic choroidal neovascularization secondary to AMD and 11 consecutive eyes of 11 patients with PCV underwent TTT. TTT was delivered through a slit lamp with an 810 nm diode laser, for a 3.0 mm beam the settings were between 300 - 400mW, for a 2.0 mm between 200 - 270mW. Fluorescein angiography (FA) was performed before the treatment, and one day and one month after the treatment. Results: FA at one day after TTT showed leakage from retinal capillary or occlusion of retinal capillary in the treated area in 6 eyes (43%) of the 14 eyes with AMD and 6 eyes (55%) of the 11 eyes with PCV. These angiographic changes completely disappeared at one month after the treatment. Conclusion: Although TTT is administered as a subthreshold photocoagulation with no visible endpoint and no ophthalmoscopically apparent chorioretinal change during the treatment, the damage to the overlying retina may occur temporarily after the treatment.

Keywords: 308 age-related macular degeneration • 346 choroid: neovascularization • 353 clinical (human) or epidemiologic studies: outcomes/complications 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×